Overview
- Republican senators led by Bill Cassidy and Lindsey Graham sent letters seeking a detailed account from FDA Commissioner Marty Makary on actions against unapproved or misbranded mifepristone sold online.
- The lawmakers also wrote to Danco Laboratories, GenBioPro, and Evita Solutions asking how they ensure compliance with the FDA’s safety program for remote prescribing and where the drugs and ingredients are produced.
- The letters urge the FDA to step up interdictions of illegal shipments with U.S. Customs and Border Protection and the Postal Inspection Service and to restore in‑person dispensing rules dropped during the pandemic.
- Supporters of the push point to new polling reported by The Federalist that seven in ten Americans favor bringing back in‑person doctor visits to obtain abortion pills.
- The action follows data cited by the Washington Examiner that abortions rose to about 1.13 million in 2025 as mail‑order access grew, including tens of thousands of shipments to people living in states with total bans.